Is there something fishy about omega-3 fatty acid compounds? Omega-3 fatty acids are a curious medicinal beast – more than just nutritional supplements, but not fully accepted as a pharmaceutical therapy...
In Drug Watch/ October, 2016 Digital health news roundup: AI is having a moment Virtual assistants like Amazon’s Alexa, paired with voice-activated Internet of Things platforms like Amazon’s Echo, could be game-changers for...
In Drug Watch, Digital Innovation, DRG Blog/ October, 2016 Digital health news roundup: Fitness trackers in study shocker Quantified Selfers got a shock as a major study of the effects of fitness trackers found that those who used them lost less weight than those...
In Drug Watch, Digital Innovation, DRG Blog/ September, 2016 The Skinny on the Obesity Market – Part 2 As has been the case for many years, it is a case of two steps forward and one step back for the obesity market. Despite the tremendous market...
In Drug Watch, Digital Innovation, DRG Blog/ September, 2016 Doctors are using Twitter as a canary in the coal mine of depression Could social data be used as a diagnostic tool? Mounting evidence suggests that the prospect of using Tweets and posts as an early warning system...
In Drug Watch, Digital Innovation, DRG Blog/ August, 2016 The Skinny on the Obesity Market – Part 1 Despite all its potential, the obesity market has still failed to take off, and the drug development pipeline is a slow moving roller coaster: the...
In Drug Watch, Digital Innovation, DRG Blog/ August, 2016 Digital health news update: Adherence tech quest heats up; Aetna's ACAxit Walgreens is launching a “gameified” digital adherence program with HealthPrize. The program, which could start by the end of 2016, will...
In Drug Watch, Digital Innovation, DRG Blog/ August, 2016 Digital health news update: Of low-risk health apps and "digital snake oil" You’ve probably read about the cupping and doping, but here’s how Olympians are using performance-enhancing digital health technology in...
In Drug Watch, Digital Innovation, DRG Blog/ August, 2016 The Shifting Goalposts of NASH Clinical Trials: Missing the Target but Achieving the Goal? Most of the time, when your lead product fails to meet the primary end point of a clinical trial it is a disaster. Even if secondary end points are...
In Drug Watch, Digital Innovation, DRG Blog/ August, 2016 Digital health news update: Symptom search revamp and a digital assist for the president's precision medicine push Google’s revamped symptom search function, just rolled out in the US for mobile, aims to get consumers better health search info but “will...
In Drug Watch, Digital Innovation, DRG Blog/ July, 2016 Key Rules for Digital Marketing Success Digital marketing is no longer one more box to check—digital technology touches each stage of a brand’s commercial arc, from clinical trials to...
In Drug Watch, Digital Innovation, DRG Blog/ July, 2016